Last 20.25 INR
Change Today 0.00 / 0.00%
Volume 0.0
SMPM On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

samrat pharmachem ltd (SMPM) Snapshot

Open
20.15
Previous Close
21.90
Day High
21.95
Day Low
20.10
52 Week High
05/2/13 - 36.85
52 Week Low
02/4/14 - 17.75
Market Cap
62.6M
Average Volume 10 Days
2.1K
EPS TTM
1.30
Shares Outstanding
3.1M
EX-Date
--
P/E TM
15.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for SAMRAT PHARMACHEM LTD (SMPM)

Related News

No related news articles were found.

samrat pharmachem ltd (SMPM) Related Businessweek News

No Related Businessweek News Found

samrat pharmachem ltd (SMPM) Details

Samrat Pharmachem Limited manufactures, exports, imports, and sells pharmaceutical chemicals in India. It primarily sells iodine and bromine salts. Its products include calcium iodate monohydrate, copper iodide, hydriodic acid, iodine, iodine monochloride, iodoethane, iodomethane, potassium bromide, potassium iodate, potassium iodide, potassium metaperiodate, sodium iodate, sodium iodide, sodium metaperiodate, and trimethyl sulfoxoniumiodide. The company’s finished products are primarily used in various industries, such as pharmaceuticals, chemicals, food, fertilizer, and salt. Samrat Pharmachem Limited also exports its products to the United States, Europe, and Japan. The company was incorporated in 1992 and is based in Mumbai, India.

Founded in 1992

samrat pharmachem ltd (SMPM) Top Compensated Officers

Chairman, Managing Director and Chief Executi...
Total Annual Compensation: 1.5M
Executive Director of Finance and Executive D...
Total Annual Compensation: 1.4M
Compensation as of Fiscal Year 2012.

samrat pharmachem ltd (SMPM) Key Developments

Samrat Pharmachem Ltd Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2013

Samrat Pharmachem Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company reported total income of INR 172.679 million compared to INR 157.52 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 3.317 million compared to INR 2.135 million a year ago. Profit from ordinary activities before tax was INR 2.297 million compared to INR 1.138 million a year ago. Net profit for the period was INR 1.644 million or INR 0.53 per basic and diluted share, compared to INR 0.896 million or INR 0.29 per basic and diluted share, a year ago. For the nine months, the company reported total income of INR 532.176 million compared to INR 533.578 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 5.204 million compared to INR 11.653 million a year ago. Profit from ordinary activities before tax was INR 0.079 million compared to INR 5.735 million a year ago. Net loss for the period was INR 1.071 million or INR 0.35 per basic and diluted share, compared to net profit for the period of INR 4.017 million or INR 1.30 per basic and diluted share, a year ago.

Samrat Pharmachem Ltd, Board Meeting, Feb 14, 2014

Samrat Pharmachem Ltd, Board Meeting, Feb 14, 2014. Agenda: To consider quarterly results.

Samrat Pharmachem Ltd Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2013

Samrat Pharmachem Ltd. announced unaudited standalone earnings results for the second quarter and six months ended September 30, 2013. For the quarter, the company reported that total income was INR 171.487 million against INR 198.451 million a year ago. Profit from operations before other income, interest & exceptional items was INR 4.093 million against INR 8.269 million a year ago. Profit from ordinary activities before tax was INR 1.091 million against INR 4.253 million a year ago. Net profit was INR 0.707 million or INR 0.23 per basic and diluted share before and after extraordinary items against INR 2.952 million or INR 0.96 per basic and diluted share before and after extraordinary items a year ago. For the six months, the company reported that total net income from operations was INR 359.497 million against INR 376.896 million a year ago. Profit from operations before other income, interest & exceptional items was INR 1.888 million against INR 10.357 million a year ago. Loss from ordinary activities before tax was INR 2.217 million against profit from ordinary activities before tax of INR 4.598 million a year ago. Net loss was INR 2.713 million or INR 0.88 per basic and diluted share before and after extraordinary items against net profit of INR 3.122 million or INR 1.01 per basic and diluted share before and after extraordinary items a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SMPM:IN 20.25 INR 0.00

SMPM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SMPM.
View Industry Companies
 

Industry Analysis

SMPM

Industry Average

Valuation SMPM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book 0.5x
Price/Cash Flow 32.0x
TEV/Sales 0.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAMRAT PHARMACHEM LTD, please visit www.samratpharmachem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.